Molecular Diagnostics

In Other News

• Position Statements Outline Evidence Standards for Multi-Cancer Detection Tests

• Gene Fusion Patterns May Flag High Risk Solitary Fibrous Tumors

• Tumor Genome Marker May Predict Treatment Benefit in Pediatric Cancers

• New RNA Origami Method Supports Faster Targeted Testing for Repeat Expansion Disorders

• FDA Approves Expanded Liquid Biopsy Panel for Advanced Cancer Profiling

• Microbial Saliva Test Could Help Triage Esophageal Cancer Risk

• Expanded DPYD Genotyping Test Supports Safer Chemotherapy Dosing

• Multi-Omics Profiling Helps Predict BCG Response and Recurrence in Bladder Cancer

• New Computational Tool Reveals Genetic Driver of Idiopathic Neuropathy

• Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

• Whole-Genome MRD Test Detects Early Recurrence in Muscle-Invasive Bladder Cancer

• Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer

• FDA-Cleared Genomic Profiling Assay Guides Treatment Selection in Solid Tumors

• ctDNA Blood Test Could Help Guide Radiotherapy in Patients with Limited Metastases

• FDA-Approved MRD Blood Test Guides Adjuvant Bladder Cancer Therapy

• Tumor Genomic Profiling Identifies High-Risk Gallbladder Cancer

• Genome Sequencing Uncovers Hidden Genetic Risks in Healthy Adults

• Sensitive Protein Marker Aids Diagnosis of Small Cell Prostate Cancer

• Rapid Multiplex PCR Test Detects 11 Gastrointestinal Pathogens from Single Sample

• Novel Algorithm Improves Detection of B-ALL Gene Fusions

• Study Finds Hidden Mpox Infections May Drive Ongoing Spread

• Genetic Markers May Help Predict Amputation Risk in Peripheral Artery Disease

• Gene Panel Shows Promise for Predicting Chemotherapy Response in TNBC